Clinical Trial Update: MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed evaluating magnesium adjunct in alcohol withdrawal syndrome (MAGMA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alcohol Withdrawal Syndrome | Phase 3 | Status: COMPLETED